# Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease

> **NCT06694597** · PHASE2 · COMPLETED · sponsor: **Fujian Medical University Union Hospital** · enrollment: 76 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Astragalus Membranaceus Root

## Key facts

- **NCT ID:** NCT06694597
- **Lead sponsor:** Fujian Medical University Union Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06694597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06694597, "Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06694597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*